Physician profile
David William Zub
NPI 1649453036
$96,840.04
in general payments reported to CMS, 2019-2025
28 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $889 · 2020: $651 · 2021: $1,932 · 2022: $12K · 2023: $19K · 2024: $51K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $66K · Food and Beverage: $8,592 · Travel and Lodging: $6,919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $66,325.00 |
| Food and Beverage | $8,591.70 |
| Travel and Lodging | $6,918.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $67,679.07 | 2022-2025 | Evoke, Evoke Scs |
| Vertos Medical, INC. | $20,093.14 | 2020-2024 | Mild Device Kit |
| Boston Scientific Corporation | $3,846.11 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $1,908.64 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Medtronic, INC. | $1,061.87 | 2021-2023 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Relievant Medsystems, INC. | $733.22 | 2022-2023 | Intracept |
| Biotronik Nro, INC. | $286.27 | 2025 | Prospera |
| Nevro Corp. | $252.31 | 2019-2024 | Senza |
| Curonix LLC | $162.71 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $156.14 | 2020-2025 | Sprint Pns System |
| Si-Bone, INC. | $96.88 | 2023-2025 | |
| Pfizer INC. | $80.88 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $56.49 | 2025 | |
| Nalu Medical, INC. | $49.23 | 2021-2022 | |
| Globus Medical, INC. | $47.66 | 2025 | Vyrsa V1, Senza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $44.41 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $41.32 | 2019-2021 | |
| Painteq LLC | $39.96 | 2024 | Painteq |
| Radius Health, INC. | $33.84 | 2019 | |
| Collegium Pharmaceutical, INC. | $28.06 | 2021 | |
| Medtronic USA, INC. | $23.24 | 2020 | |
| Spinal Simplicity, LLC | $21.49 | 2024 | Ha Minuteman G3-R |
| Stryker Corporation | $20.58 | 2025 | Optablate |
| Tricoast Surgical Solutions LLC | $19.53 | 2025 | |
| Amgen INC. | $16.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.85 | 2019 | |
| Supernus Pharmaceuticals, INC. | $12.21 | 2019 | |
| Allergan, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Zub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.